ARTcrystal® process for industrial nanocrystal production - Optimization of the ART MICCRA pre-milling step

International Journal of Pharmaceutics

Volumn 465, Issue 1-2, 2014, Pages 388-395

  Scholz, Patrik ^a,b   Arntjen, Anja ^a   Müller, Rainer H ^b   Keck, Cornelia M ^a,b  

^a UNIVERSITY OF APPLIED SCIENCES KAISERSLAUTERN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

ART MICCRA; ARTcrystals; Nanocrystals; Nanosuspension; Rotor stator; Rutin

Indexed keywords

NANOCRYSTAL; NANOMATERIAL; RUTOSIDE; ANTIOXIDANT; NANOPARTICLE;

ARTCRYSTAL PROCESS; ARTICLE; CHEMICAL PROCEDURES; COST; FLOW RATE; FOAMING; NANOSUSPENSION; PARTICLE SIZE; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; PROCESS OPTIMIZATION; SUSPENSION; TEMPERATURE; VALVE; VELOCITY; CHEMISTRY; CRYSTALLIZATION; DEVICES; EQUIPMENT DESIGN; MOTION; NANOTECHNOLOGY; PHARMACEUTICS; PRESSURE; PROCEDURES; TIME;

ANTIOXIDANTS; CRYSTALLIZATION; EQUIPMENT DESIGN; MOTION; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; PRESSURE; RUTIN; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE; TIME FACTORS;

EID: 84897954628     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.02.026     Document Type: Article

References (25)

1. S. Acar Kübart, and C.M. Keck Laser diffractometry of nanoparticles, frequent pitfalls & overlooked opportunities J. Pharm. Technol. Drug Res. 2 2013 10.7243/2050-120X-2-17
2. L. Al Shaal, R. Shegokar, C.M. Keck, and R.H. Müller Apigenin nanocrystals for dermal application Controlled Release Society German Local Chapter Annual Meeting Jena, March 15-16, 2011 2011
3. ART Labor- und Prozesstechnik GmbH Product catalague 2013 http://www.miccra.com
4. Auweter, H., Bohn, H., Heger, R., Horn, D., Siegel, B., Siemensmeyer, K., 2002. Precipitated water-insoluble colorants in colloid disperse form. US Patent 6,494,924. USA, BASF AG.
5. M.P. Badve, P.R. Gogate, A.B. Pandit, and L. Csoka Hydrodynamic cavitation as a novel approach for delignification of wheat straw for paper manufacturing Ultrason. Sonochem. 21 2014 162 168
6. J. Breitenbach Melt extrusion: from process to drug delivery technology Eur. J. Pharm. Biopharm. 54 2002 107 117 (Pubitemid 34919382)
7. R. Chen Tailor-made antioxidative nanocrystals: production and in vivo efficacy (Ph.D. Thesis) 2013 Freie Universität Berlin
8. P. Gassmann, M. List, A. Schweitzer, and H. Sucker Hydrosols - alternatives for the parenteral application of poorly water soluble drugs Eur. J. Pharm. Biopharm. 40 1994 64 72 (Pubitemid 24165685)
9. Innovadex Plantacare 2000 UP 2013 http://www.innovadex.de/PersonalCare/ Detail/804/34234/Plantacare-2000-UP
10. C.M. Keck Cyclosporine Nanosuspensions: Optimised Size Characterisation & Oral Formulations 2006 Freie Universitaet Berlin
11. C.M. Keck Particle size analysis of nanocrystals: improved analysis method Int. J. Pharm. 390 2010 3 12
12. Keck, C.M., 2011. Nanocrystals and amorphous nanoparticles and method for production of the same by a low energy process. EP11185527.6, PharmaSol GmbH.
13. C.M. Keck, and R.H. Müller Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation Eur. J. Pharm. Biopharm. 62 2006 3 16 (Pubitemid 41736019)
14. C.M. Keck, and R.H. Müller Size analysis of submicron particles by laser diffractometry - 90% of the published measurements are false Int. J. Pharm. 355 2008 150 163
15. G.G. Liversidge, and P. Conzentino Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats Int. J. Pharm. 125 1995 309 313
16. Malvern A basic guide to particle characterization Inform White Paper MRK1806-01 2012 Malvern Instruments Worcestershire, UK
17. E. Merisko-Liversidge, G.G. Liversidge, and E.R. Cooper Nanosizing: a formulation approach for poorly-water-soluble compounds Eur. J. Pharm. Sci. 18 2003 113 120 (Pubitemid 36184748)
18. P.R. Mishra, L. Al Shaal, R.H. Müller, and C.M. Keck Production and characterization of hesperetin nanosuspensions for dermal delivery Int. J. Pharm. 371 2009 182 189
19. R.H. Müller, A. Dingler, T. Schneppe, and S. Gohla Large scale production of solid lipid nanoparticles (SLN™) and nanosuspensions (DissoCubes™) D. Wise, Handbook of Pharmaceutical Controlled Release Technology 2000 359 376
20. R.H. Müller, S. Gohla, and C.M. Keck State of the art of nanocrystals - special features, production, nanotoxicology aspects and intracellular delivery Eur. J. Pharm. Biopharm. 78 2011 1 9
21. R.H. Müller, J. Hanisch, R. Mauludin, R. Petersen, and C.M. Keck Rutin drug nanocrystals for dermal cosmetic application AAPS Annual Meeting, San Diego, November 9-15, 2007 2007
22. R.H. Müller, K. Mäder, and K. Krause Verfahren zur schonenden Herstellung von hochfeinen Micro-/Nanopartikeln 2000 PCT Application PCT/EP00/06535 Germany
23. R.H. Müller, R. Shegokar, S. Gohla, and C.M. Keck Nanocrystals: production, cellular drug delivery, current and future products A. Prokop, Intracellular Delivery: Fundamentals and Applications, Fundamental Biomedical Technologies vol. 5 2011 Springer Science + Business Media B.V. Dordrecht, Heidelberg, London, New York 411 432
24. S. Stegemann, F. Leveiller, D. Franchi, H. de Jong, and H. Linden When poor solubility becomes an issue: from early stage to proof of concept Eur. J. Pharm. Sci. 31 2007 249 261 (Pubitemid 47079001)
25. S. Tommasini, D. Raneri, R. Ficarra, M.L. Calabro, R. Stancanelli, and P. Ficarra Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin J. Pharm. Biomed. Anal. 35 2004 379 387 (Pubitemid 38520131)